These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9570364)

  • 1. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
    Kim KS; Lee YI
    Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic imprinting of IGF2 and H19 in human meningiomas.
    Müller S; Zirkel D; Westphal M; Zumkeller W
    Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
    Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of imprinting of igf2 in renal-cell carcinomas.
    Oda H; Kume H; Shimizu Y; Inoue T; Ishikawa T
    Int J Cancer; 1998 Jan; 75(3):343-6. PubMed ID: 9455791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
    Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
    Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
    Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK
    Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM; Vu TH; Hoffman AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
    Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI
    Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions.
    Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K
    J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.
    Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT
    Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
    Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
    Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.
    Frevel MA; Sowerby SJ; Petersen GB; Reeve AE
    J Biol Chem; 1999 Oct; 274(41):29331-40. PubMed ID: 10506193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
    Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Genomics; 2008 May; 91(5):443-50. PubMed ID: 18358696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.